Buy ImmunoGen Stock | IMGN Stock Price & Latest News | Public.com
IMGN

ImmunoGen

$0.00 (0.00%)Today
    View ImmunoGen (IMGN) stock trends here

    About IMGN

    ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded in March 1981 and is headquartered in Wa...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.16
    0.04
    -0.08
    -0.2
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.20

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,64B
    Volume310
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$10.88
    1 Year Low$1.95
    Open$8.79
    High$8.96
    Low$8.56

    Buy any stock with any amount of money.

    Download the App
    Download the app